It has been a rough year for many health-care-focused hedge funds, with a number of them either in the red or barely breaking even.
Not Sarissa Capital Management’s funds, however.
Its main long-short fund, Sarissa Capital, was up 18.1 percent in the first half of the year, while Sarissa Capital Domestic Fund II, the long-only fund it launched a year ago, was up 14.9